ALVOAlvotech
$4.59-48% 1Y
$4.59
$3.0052 weeks$8.72
Is the price fair?
What ALVO's price assumes
Alvotech trades at 45.9× earnings against 21.0× for the median Drug Manufacturers - Specialty & Generic name, more expensive than its own group.
45.9
Trailing P/E · Drug Manufacturers - Specialty & Generic median 21.0 · 2.19× the median: the market pays up for this one
Details›
- Healthcare median P/E503 names
- 27.9
- Drug Manufacturers - Specialty & Generic median P/E44 names
- 21.0
- Market capitalisation312.0 million shares, counted Dec 31, 2025
- $1.43B
Multiples from SEC filings and end-of-day closes; implied growth from a reverse discounted cash flow. Group medians across the names Ryufin tracks.
Drug Manufacturers, Specialty & Generic
Ranks #27 of 39 by RyuScore